| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 3,878,951 | 3,230,596 |
| Net change in cash and cash equivalents | -6,157,860 | -4,447,212 |
| Cash and cash equivalents at beginning of period | 10,017,942 | - |
| Cash and cash equivalents at end of period | 3,860,082 | - |
Cadrenal Therapeutics, Inc. (CVKD)
Cadrenal Therapeutics, Inc. (CVKD)